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INTRODUCTION
Myotonic dystrophy (DM) is the most common
muscular dystrophy in adults. Two known genetic
subtypes include DM1 (myotonic dystrophy type 1,
Steinert disease; OMIM 160 900) and DM2 (myo-
tonic dystrophy type 2, proximal myotonic myopa-
thy; OMIM 602 668). DM1 is caused by the expan-
sion of a CTG triplet repetition in the 3‘ un-transla-
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Myotonic dystrophy (DM) is the most common muscular dystrophy in adults.
Two known genetic subtypes include DM1 (myotonic dystrophy type 1) and
DM2 (myotonic dystrophy type 2). Genetic testing is considered as the only
reliable diagnostic criterion in myotonic dystrophies. Relatively little is known
about DM1 and DM2 myopathology. Thus, the aim of our study was to charac-
terise light and electron microscopic features of DM1 and DM2 in patients with
genetically proven types of the disease. We studied 3 DM1 cases and 15 DM2
cases from which muscle biopsies were taken for diagnostic purposes during
the period from 1973 to 2006, before genetic testing became available at our
hospital. The DM1 group included 3 males (age at biopsy 15–19). The DM2
group included 15 patients (5 men and 10 women, age at biopsy 26–60). The
preferential type 1 fibre atrophy was seen in all three DM1 cases in light mi-
croscopy, and substantial central nucleation was present in two biopsies.
Electron microscopy revealed central nuclei in all three examined muscle biopsies.
No other structural or degenerative changes were detected, probably due to the
young age of our patients. Central nucleation, prevalence of type 2 muscle fibres,
and the presence of pyknotic nuclear clumps were observed in DM2 patients in
light microscopy. Among the ultrastructural abnormalities observed in our DM2
group, the presence of internal nuclei, severely atrophied muscle fibres, and lipo-
fuscin accumulation were consistent findings. In addition, a variety of ultrastructur-
al abnormalities were identified by us in DM2. It appears that no single ultrastruc-
tural abnormality is characteristic for the DM2 muscle pathology. It seems, how-
ever, that certain constellations of morphological changes might be indicative of
certain types of myotonic dystrophy. (Folia Morphol 2011; 70, 2: 121–129)
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ted region of the DM protein kinase gene on 19q13,
while DM2 is caused by the expansion of a CCTG
tetranucleotide repetition in the first intron of the
zinc finger 9 (ZNF 9) gene on 3q21 [18, 19]. These
two diseases share many of the same clinical cha-
racteristics, such as an autosomal dominant inheri-
tance pattern, myotonia, myopathy, as well as multi-
organ involvement affecting the heart, brain, and
endocrine system [14, 15, 23, 26, 31, 33]. Certain
clinical features, such as typical distal muscle weak-
ness in DM1, proximal muscle weakness in DM2, mild
if any facial involvement in DM2, prominent cogni-
tive impairment in DM1, and the absence of a con-
genital form in DM2, provide some differentiating
clinical clues.
However, a considerable number of patients with
the genetically proven type of the disease have un-
usual phenotypic presentations [22, 32, 33]. Thus
genetic testing is considered as the only reliable dia-
gnostic criterion in myotonic dystrophies. Whereas
the diagnosis of DM1 is relatively easy on clinical
grounds and can be easily confirmed by DNA test,
the diagnosis of DM2 may often be overlooked be-
cause of subtle and non-characteristic phenotype
features.
Relatively little is known about DM1 and DM2
myopathology. Muscle histopathology of DM1 is
considered rather typical, although no detailed study
based on a large series of patients has ever been
performed. Muscle biopsy was rarely needed to con-
firm the clinical diagnosis of DM1. As the genetic
confirmation of DM1 became widely available, mus-
cle biopsy was removed from the guidelines for clin-
ical diagnosis of DM1. First reports on skeletal mus-
cle pathology in myotonic dystrophy were published
in the late 1960s [3, 12]. A combination of type 1
fibre atrophy and type 2 fibre hypertrophy was
found and since then has been regarded as highly
specific for myotonic dystrophy as well as rarely seen
in other muscle disorders.
Dubowitz [8] in his textbook edited in 1985 re-
ported on the histopathological analysis of 12 adult
patients with “classical myotonic dystrophy” since
no molecular diagnosis was available at that time.
Interestingly, identical observations are presented
as “pathological characteristics of DM1” in the lat-
est edition of “Muscle biopsy: a practical approach”
[9]. Changes such as multiple internal nuclei (often
in long chains), sarcoplasmic masses, and ring fi-
bres were recognised as most common. Subsequent-
ly, histopathological changes in early stages of the
DM1 were observed. These, according to Dubowitz,
were a disparity between the size of type 1 fibres
and type 2 fibres with atrophy of type 1 fibres and
hypertrophy of the type 2 fibres. Similar abnorma-
lities were described by Karpati et al. [17] in their
textbook in 2001 as typical findings for myotonic
dystrophy with unstable CTG repetition on chromo-
some 19q13.3.
Harper, in his monograph [14], also presented
data on skeletal muscle pathology in myotonic dys-
trophy. Among typical changes listed as most im-
portant were abundant central nuclei, common ring
fibres, and type 1 fibre atrophy. Unfortunately, no
detailed analysis of these findings was provided.
Myopathological data are more extensive for
DM2 than for DM1. Several papers describing large
series of muscle biopsies from DM2 patients [1, 3,
25, 28, 34] as well as many case reports [20, 32, 35]
have been published. Most of these studies feature
a rather homogenous pattern of muscle pathology
in DM2. Multiple internal nuclei, predominant type
2 fibre atrophy and pyknotic nuclear clumps seem
to be typical constellations of muscle changes [1].
Only in one report [6] neither characteristic for DM2
abnormalities were found nor were differences be-
tween DM1 and DM2 biopsies noted.
We are unaware of any systematic electron mi-
croscope examination of myotonic dystrophy mus-
cle biopsies. Several authors have reported on mus-
cle ultrastructure in DM1. Results of early studies
are summarised in Harper’s monograph [14]. A va-
riety of pathological changes such as degenerative
changes of myofibrils and diverse abnormalities of
the sarcotubular system [24, 29] were observed,
none of them was considered specific for the di-
sease.
For the DM2, electron microscope studies are also
scarce. The appearance of non membrane-bound
vacuoles consistent with either dilated sarcoplasmic
reticulum or a portion of the T-tubule system was
presented in one case [32].
The aim of our study was to characterise light and
electron microscopic features of DM1 and DM2 in pa-
tients with a genetically proven type of the disease.
MATERIAL AND METHODS
Patients
From our group of 135 patients with genetically
proven DM subtype (93 DM1 and 42 DM2 ) we stud-
ied 3 DM1 cases and 15 DM2 cases who had muscle
biopsy taken for diagnostic purposes during the
period from 1973 to 2006, before genetic testing
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became available at our hospital. The DM1 group
included 3 males (age at biopsy 15–19). The DM2
group included 15 patients (5 men and 10 women,
age at biopsy 26–60).
Molecular genetic analysis
The DNA testing for DM1 and DM2 was per-
formed as previously described by other authors [2,
18, 27, 36].
Muscle biopsy specimens
Three samples were available from the DM1
group, 2 from biceps brachii, and 1 from the del-
toid muscle. In the DM2 group 16 muscle samples
(13 from vastus lateralis and 3 from biceps brachii)
were available from 15 patients. One patient from
this group had 2 muscle biopsies taken, the second
after an interval of 10 years.
Muscle biopsies were processed using standard
histological procedures. One part of the sample was
frozen in isopentane, cooled in liquid nitrogen, and
sectioned at 6 mm in a cryostat; another part was
fixed in 2.5% glutaraldehyde and prepared routine-
ly for electron microscopy.
Light microscopic evaluations were performed on
transverse sections conventionally stained with hae-
matoxylin-eosin (H & E), Gomori trichrome, NADH-
-dehydrogenase, succinie dehydrogenase, (SDH) and
ATP-ase after pre-incubation at pH 9.4 and 4.35.
Light microscopy
For the purpose of this study all samples were
re-evaluated by two non-blinded authors (A.N.-P.
and A.K.). Pathological changes such as central nu-
cleation, selective muscle fibre type, prevalence, and
atrophy, nuclear clumps, angulated fibres, sarcoplas-
mic masses, ring fibres, necrosis, and fibrosis were
assessed in every case. The number of muscle fibres
evaluated in each sample ranged from 200 to 250.
Central nucleation and other structural changes were
assessed in selected area H&E staining, whereas fi-
bre type composition and fibre type diameter were
assessed in serial sections in the same area in
ATPase pH 9.4. A fibre diameter range of 40–80 µm
for males and 30–70 µm for females was accepted
as normal [4]. As for fibre type composition [4, 5,
16], the following approximate proportions were ac-
cepted: type 1 — 30–40% and type 2 — 60–70%.
The presence of pyknotic nuclear clumps was evalu-
ated in the same area and calculated per 100 fibres.
Immunohistochemistry was not performed since
frozen muscle tissue was not available for the ma-
jority of the patients.
Electron microscopy
Ultrastructural examination of muscle samples
was performed to evaluate fine structural abnormal-
ities of muscle fibres and to better characterise the
pyknotic nuclear clumps. Special attention was paid
to the pathological muscle changes indicative of
denervation.
RESULTS
Clinical and light microscopic analysis of 3 DM1




Sarcoplasmic masses, ring fibres, necrosis, and
fibrosis were extremely rare or absent in all exami-
ned biopsies (either DM1 or DM2). Our findings in
DM1 (Table 1) revealed the presence of substantial
internal nucleation in two cases and absence of in-
ternal nuclei in one case. Central nuclei were usually
single on the cross section and were mostly detect-
ed in atrophied fibres. A predominance of type 1
fibres was found in two cases whereas in one case
Table 1. Results of light microscopy analysis in 3 myotonic dystrophy type 1 biopsies
No. M/F Age at Muscle Internal Fibre type Fibre type Nuclear
biopsy nuclei composition diameter [µm] clumps
Type 1 Type 2 Type 1 Type 2
1 M 18 Biceps 23% 36% 64% 35 ± 8 61 ± 8 1
2 M 15 Biceps – 53% 47% 27 ± 13 54 ± 11 –
3 M 19 Deltoid 10% 56% 44% 29 ± 11 52 ± 13 –
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type 2 fibres were predominant. Preferential type 1
fibre atrophy was observed in all three cases. The
diameter of type 2 muscle fibres was within normal
limits. A single nuclear clump was seen in one case.
In DM2 (Table 2) we found central nucleation
(ranging from 2 to 56%) in all but one biopsy. Cen-
tral nuclei were usually multiple and occurred fre-
quently in normotrophic as well as hypertrophic fi-
bres. The percentage values of type 1 and type 2
fibres were within the normal range in only two sam-
ples. In the majority of specimens type 2 muscle fi-
bre prevalence (from 38 to 81%) was encountered.
However, in four muscle biopsies, type 2 muscle fi-
bre decrease (from 62 to 19%) was encountered.
An analysis of muscle fibre diameter showed
values from 31 to 81 µm. Atrophy of type 1 af-
fected two males and one female, whereas atro-
phy of type 2 fibres was noted in two female pa-
tients. Hypertrophy of type 1 occurred in two fe-
males and hypertrophy of type 2 fibres was found
in four females and two males. Single scattered
atrophic angulated fibres were encountered in the
majority of DM2 biopsies. Pyknotic nuclear clumps
(fibres with preserved nuclei and severely reduced
cytoplasm) were observed in all but one muscle
biopsy (with a frequency of 2 to 28 per 100 fi-
bres). Fibre type grouping or group atrophy was
not seen in any biopsy.
Electron microscopy
Myotonic dystrophy type 1 (DM1). Electron
microscopy revealed central nuclei in all three exami-
ned muscle biopsies. On the longitudinal section such
nuclei were often arranged in a row. No other struc-
tural or degenerative changes were detected.
Myotonic dystrophy type 2 (DM2). All exami-
ned muscle samples showed ultrastructural abnor-
malities. A variety of pathological but non-specific
changes such as central nucleation, atrophied fi-
bres, cytoplasmic bodies, honey comb-like struc-
tures, IBM-type cytoplasmic inclusions, and ragged-
red fibres were identified. The remaining abnormali-
ties were present in one or two of the examined
biopsies and, most often, in single fibres. Only the
presence of central nucleation, severely atrophied
fibres, and lipofuscin accumulation were consistent-
ly found.
Central nuclei were observed in many fibres in
all biopsies. Such nuclei were usually multiple with-
in the fibre. Muscle fibres containing internal nuclei
Table 2. Results of light microscopy analysis in 16 myotonic dystrophy type 2 biopsies
No. M/F Age at Muscle Internal Fibre type Fibre type Nuclear
biopsy nuclei composition diameter [µm] clumps
Type 1 Type 2 Type 1 Type 2
1 M 30 VL 2% 28% 72% 31 ± 16 72 ± 10 –
2 F 54 VL 52% 40% 60% 52 ± 13 48 ± 18 14
3 F 51 VL 28% 64% 36% 28 ± 11 78 ± 8 13
4 F 33 Biceps – 26% 74% 62 ± 19 43 ± 12 2
5a M 30 VL 28% 41% 59% 75 ± 16 81 ± 13 5
5b M 40 VL 36% 44% 56% 69 ± 12 80 ± 11 7
6 F 57 VL 40% 18% 82% 59 ± 12 75 ± 9 16
7 F 59 VL 14% 81% 19% 80 ± 9 77 ± 15 28
8 F 50 VL 56% 63% 37% 80 ± 8 30 ± 8 18
9 F 55 Biceps 28% 49% 51% 35 ± 8 65 ± 8 8
10 F 53 VL 48% 66% 34% 50 ± 8 30 ± 8 6
11 F 37 Biceps 10% 38% 62% 45 ± 8 40 ± 8 5
12 M 26 VL 8% 41% 59% 48 ± 9 52 ± 16 4
13 M 34 VL 23% 46% 54% 33 ± 7 61 ± 12 3
14 F 60 VL 15% 22% 78% 62 ± 11 75 ± 14 5
15 M 31 VL 6% 42% 58% 55 ± 13 62 ± 8 6
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were not usually atrophied. The appearance of nu-
clei varied from normal to irregular, hyperchroma-
tic, invaginated, and fragmented. No intranuclear
inclusions were noted.
Atrophied fibres (Fig. 1) in the cytoplasm con-
tained almost no contractile material, or fragments
of the Z line and only a few scattered mitochon-
dria. Such fibres were devoid of a nucleus (Fig. 1A)
or contained one to more than ten nuclei or nucle-
ar fragments (Fig. 1B–F). Nuclei differed in appear-
ance — from large and round (Fig. 1B) to irregular
and hyperchromatic (Fig. 1F). The basement mem-
brane of atrophied fibres was regular and not fold-
ed. No basement membrane processes or loops
were ever observed. Neighbouring fibres showed
no features of denervation.
Lipofuscin accumulation occurred in numerous
severely atrophied (Fig. 2A) as well as non-atrophied
fibres, most often aligned under the sarcolemma.
Lipofuscin was present in the form of bodies, which
were heterogeneous in composition and contained
granules of different sizes and densities. Such bo-
dies were irregular in shape and often limited by
a single membrane.
Cytoplasmic bodies (Fig. 2B) were observed
in two biopsies both in severely atrophied and
moderately atrophied fibres. They consisted of
a dense round centre and a peripheral zone of
radially oriented filaments. Honey comb-like
structures were present as aggregates of highly
regular tubular components and were observed
in extremely atrophied fibres (Fig. 2C). They were
Figure 1. Electron microscopic picture of severely atrophied muscle fibres in DM2 patients; A. Muscle fibre devoid of nucleus, ¥5000;
B–F. Muscle fibres containing different numbers of nuclei; B. ¥3000; C. ¥4000; D. ¥4000; E. ¥3000; F. ¥25 000.
Figure 2. Electron microscopic abnormalities observed in DM2 biopsies; A. Lipofuscin accumulation, ¥4000; B. Cytoplasmic body,
¥15 000; C. Honey comb-like structure, ¥25 000; D. Concentric laminated body, ¥20 000; E. IBM-type cytoplasmic inclusion, ¥25 000;
F. Ragged-red fibre, ¥2500.
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encountered in two atrophied muscle fibres in
two muscle biopsies.
Concentric laminated body fibres (Fig. 2D) were
observed as a cylindrical structure of 9 concentric
laminae with glycogen granules in the centre.
Electron microscopy revealed non-membrane-
bound vacuoles in several muscle fibres in two bi-
opsies. They were located both in the centre and at
the periphery of fibers and usually contained mem-
branous whorls, poorly defined debris, and, in one
case, IBM-type inclusions.
IBM-type cytoplasmic inclusions were observed
in several muscle fibres in one biopsy. They appeared
as clusters of randomly-oriented tubulo-filaments
measuring 16–21 nm in diameter (Fig. 2E). IBM-type
inclusions were often located close to vacuoles,
sometimes filling their lumen together with myelin
whorls. No such inclusions were identified within
muscle nuclei.
Disordered sarcomeres appeared as mini-cores
(small unstructured areas within the fibre) and
Z-line irregularities.
Ragged-red fibre was observed in only one bio-
psy as a fibre with marked mitochondrial prolifera-
tion (Fig. 2F). Mitochondria were large, irregular in
shape, and often contained whorled cristae and
paracrystalline inclusions.
Ring fibres were present only in one muscle bio-
psy. They consisted of a central longitudinal core of
normally oriented myofibrils encircled by a thin pe-
ripheral band of transversely oriented myofibrils.
The normal sarcomere pattern in the peripheral band
was preserved, although some sarcomeres were
shorter and split. No sarcoplasmic masses were en-
countered.
DISCUSSION
Our analysis of DM1 biopsies included only three
cases. As already mentioned, muscle biopsy is no
longer considered necessary in the diagnosis of DM1.
The biopsies presented here were taken long before
molecular analysis became available. In all three cas-
es the patients were young, and this fact probably
explains the scarcity of histopathological alterations
and the lack of degenerative changes. According to
Dubowitz [9], as the disease progresses, more and
more myopathic changes make their appearance.
Nevertheless, preferential type 1 fibre atrophy was
seen in all three cases, and substantial central nu-
cleation was present in two biopsies. Interestingly,
the two changes (ring fibres and sarcoplasmic mas-
ses) presented in many textbooks [9, 10, 17] as the
most typical, were not found in our material. One
might hypothesize that such pathological changes
appear in affected muscles with time, as a result of
work overload and/or abortive regeneration.
It is worth mentioning that reports on DM1 myo-
pathology are scarce [3, 24, 29, 34] and very often
based on small series or even on single cases. Most
of them were published before the era of molecular
diagnosis. Nevertheless, the findings consistently
reported were type 1 atrophy, type 2 hypertrophy,
multiple internal nuclei — often in long chains, sar-
coplasmic masses, and increased incidence of ring
fibres. Why central nucleation should occur is poor-
ly understood. Harper, in his monograph [14], con-
cludes that there is no evidence to support the view
that central nucleation results from continuing divi-
sion of the centrally placed nuclei or as a result of
continued inward migration of myonuclei. It is also
suggested in the literature [13] that internal nuclei
in type 1 muscle fibres in DM1 might indicate its
incomplete maturation. In fact, such nuclei are lo-
cated in the centre, at the early stages of the di-
sease, being single and on the cross section, where-
as in the longitudinal section they are often arranged
in a row. Such a constellation of findings resembles
features of muscle fibre immaturity.
The reason for the selective atrophy of type 1
muscle fibres in DM1 remains unknown. Such atro-
phy occurs in a variety of congenital neuromuscular
disorders. It is suggested [17] that the small size of
type 1 fibres may be due to their failing to attain
their normal diameter during development. In fact,
type 1 muscle fibre atrophy is considered as an ear-
ly manifestation of the DM1, and it can be present
at the pre-clinical stage of the disease. Such prefer-
ential atrophy might also be related to pathogenic
effects of the CTG repetition-containing RNA in slow
and fast muscle fibres.
Early reports on DM2 muscle pathology suggest-
ed that the changes were similar to DM1 [7, 26].
Recent muscle biopsy studies, however, have un-
equivocally reported preferential type 2 muscle fi-
bre atrophy and central nucleation, as well as the
presence of angulated fibres and pyknotic nuclear
clumps [1, 25, 28, 34].
Our findings revealed a similar spectrum of light
microscopic abnormalities. Analysis of general his-
topathological changes disclosed abnormalities in
every examined biopsy. However, the small number
of patients, different biopsied muscles, different
gender, and age at biopsy made statistical analysis
unfeasible. The most frequent pathological alter-
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ation in our cohort was central nucleation (15/16
biopsies) and pyknotic nuclear clumps (15/16 biop-
sies). These data confirm previous reports by other
authors [1, 25, 28, 34].
Changes in the sarcolemmal nuclei are also promi-
nent in DM2. Location of nuclei in the centre of
muscle fibres is seen in many conditions such as dif-
ferent types of myopathy and chronic neuropathies.
Hypertrophied muscle fibres, before they split, con-
tain internal nuclei. Nevertheless, the large number
of internal myonuclei is considered a hallmark of
myotonic dystrophy. In DM1, internal nuclei were
found selectively in small type 1 muscle fibres, where-
as in DM 2 most centronucleated type 2 muscle fi-
bres were not atrophic [1]. This may suggest a dif-
ferent, yet unknown pathomechanism(s) of central
nucleation of muscle fibres in DM1 and in DM2.
The expression “pyknotic nuclear clumps” is used
in the literature for fibres with preserved nuclei and
extremely reduced cytoplasm. They are frequently
seen in denervation and in different myopathies as
an end-stage muscle fibre atrophy.
Their origin in different diseases may be diffe-
rent and not necessarily result from a lack of inner-
vation. It is conceivable that other pathogenic mecha-
nisms (trophic or toxic) are involved in DM2 and,
due to factors unknown thus far, pyknotic muscle
clumps are formed. In fact, in none of the DM2 bi-
opsies examined by us, typical pathological features
of denervation were found.
The observed pathology in our group also includ-
ed type 2 fibre prevalence (12/16 biopsies). Such
a prevalence, although to a lesser extent, was al-
ready noted in Schoser’ series [28], and it was ab-
sent in Pisani’s report [25]. The reason for such dis-
crepancies remains obscure and cannot be explained
by different patient characteristics or by the mor-
phometric norms adopted.
Preferential type 2 fibre atrophy is considered
a typical alteration in DM2 and was reported with
variable frequency in the majority of recent papers
[1, 25, 28, 34] summarising histopathological find-
ings in larger groups of patients. Vihola et al. [34]
found such atrophy in all nine examined patients.
Schoser et al. [28] described moderate type 2 atro-
phy in about two-thirds of his fifty-seven DM2 pa-
tients. In Pisani [25] series type 2 fibre atrophy was
encountered (ranging from 9% to 23%) in all exami-
ned muscles except for the male biceps, whereas
Bassez [1] reported such atrophy in all eight exami-
ned patients (the muscle was not specified). Nor-
mal values for fibre diameters in all cited papers were
identical to ours. Interestingly, in our group, prefer-
ential type 2 fibre atrophy was found only in 2/16
muscles — in both cases in female VL. Hypertrophy
of type 2 fibres occurred in four females and two
males.
Type 1 fibres were less affected in the DM2 group
— only in two cases type 1 fibre atrophy was noted.
Thus it seems that DM2 can be “type 2 muscle fibre
disease” characterised by type 2 muscle fibre atro-
phy, hypertrophy, and central nucleation. Detailed
studies by Pisani et al. [25] proved that a high pre-
valence of central nucleation occurred among hy-
pertrophic type 2 fibres, and this observation had
a high predictive value for the diagnosis of DM2.
Why preferential involvement of type 2 fibres in DM2
should occur remains unknown. One of the possible
pathogenetic mechanisms might be a toxic effect
of the CCTG repetition-containing RNA on type 2 muscle
fibres.
The results of our study confirm previous obser-
vations [1, 25, 28, 34] that DM1 and DM2 are char-
acterised by different myopathological alterations
selectively affecting type 1 and type 2 muscle fibres.
There are only a few studies on muscle ultrastruc-
ture in myotonic dystrophy. Early studies [24, 29],
which were summarised in Harper’s monograph
[14], inevitably included patients without genetic
confirmation. A variety of pathological changes, such
as degeneration of myofibrils with the Z and I band
affection as well as proliferation of sarcotubular sys-
tem, were observed. Although none of the reported
degenerative alterations was considered specific for
the disease, it was assumed that severity of chang-
es was parallel to the degree of muscle involvement.
The authors are aware of only one electron mi-
croscopic evaluation of the muscle in genetically
confirmed myotonic dystrophy. Toth et al. [32] re-
ported pathological evidence of subsarcolemmal
vacuolation in two DM2 patients. They also noted
cleft muscle fibre nuclei in both patients as well as
angulated atrophic fibres and pyknotic nuclear
clumps in one.
The results of our ultrastructural studies in DM1
patients in our group revealed very few abnormali-
ties. This might be due to their young age at biop-
sy. As a matter of fact, only central nucleation sug-
gested the diagnosis of myotonic dystrophy. Patho-
logical changes considered most typical for DM1 —
sarcoplasmic masses and ring fibres — were absent
in our material. Neither abnormalities in the sarcotu-
bular system nor degenerative changes in myofibrils
were encountered. This is in agreement with the
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observations of Mussini [24] and Dubowitz [9] that
the severity of the pathological changes parallel the
progression of the disease.
Among the ultrastructural abnormalities ob-
served in our DM2 group, the presence of internal
nuclei, severely atrophied muscle fibres, and lipo-
fuscin accumulation were consistent findings. Mul-
tiple internal nuclei were usually found in normal-
size or hypertrophied fibres showing no obvious fea-
tures of splitting, degeneration, and/or regeneration.
These observations exclude already well-known
mechanisms of central nucleation and suggest oth-
ers which remain to be identified.
Our study confirms the previously reported pres-
ence of severely atrophied fibres and nuclear clump-
ing in DM2 biopsies. Ultrastructural evaluation
showed a population of very small fibres consisting
of fibres devoid of nuclei as well as some contain-
ing multiple nuclei. It is widely accepted that mus-
cle fibre atrophy may result from both denervation
and myopathy. The electron-microscopic picture of
chronic denervation is well known, and diverse ul-
trastructural changes have been described both in
experimental animals [11] and in humans [21, 30].
The severely atrophic fibres and pyknotic nuclear
clumping identified by us in examined biopsies
might suggest denervation as a possible pathoge-
netic factor in DM2 [34]. However, no other typical
pathological features of denervation have been
found in electron microscopy. The mechanism lead-
ing to muscle fibre atrophy in DM2 remains at the
moment unclear.
The other constant finding in the DM2 muscle was
lipofuscin accumulation. It is generally accepted that
lipofuscin accumulation is prominent in long-lived
postmitotic cells. The origin of lipofuscin granules in
muscle remains uncertain; they might be lysosomal
residual bodies originating in autophagic vacuoles,
or they might originate from mitochondrial lipids.
Lipofuscin accumulation, however, is considered
a nonspecific finding since it was described in differ-
ent neuromuscular disorders, neurogenic and myo-
pathic, hereditary as well as acquired.
A variety of ultrastructural abnormalities were
identified by us in DM2. All of them were present in
one or two examined biopsies and usually in one or
in very few muscle fibres. To our surprise, only one
ring fibre was identified in all the DM2 biopsies.
Therefore, it would appear that no single ultrastruc-
tural abnormality is characteristic of DM2 muscle
pathology. It seems, however, that certain constel-
lations of morphological changes might be indica-
tive of a certain types of myotonic dystrophy. As
was pointed out earlier, muscle biopsy is no longer
recommended in the diagnosis of typical myotonic
dystrophy, but it may still be useful in characteris-
ing different, less common phenotypes of myotonic
dystrophy.
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